Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AtWoRC: Vortioxetine and Work Productivity in MDD
NCT02332954Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Feb 2015
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vortioxetine in major depressive disorder (MDD), sponsored by Lundbeck. Started Feb 2015; status: completed.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02332954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332954.